What we do
Boehringer Ingelheim BioXcellence™ offers the full spectrum of services for late-stage products – with a hard-won reputation as a reliable partner accompanying you throughout the lifecycle of your product. We can help you to turn biologic innovation into commercial reality.
Trusted partners in…
Mammalian Cell Cultures
Fast and tailored transfers
Upstream and downstream processing
Launch preparation and regulatory support
Clinical and commercial supply
GMP facilities licensed by EMA, FDA & MHLW
All analytic capabilities inhouse
GMP batch release testing
Manufacturing of Fab fragment, Fc fusion proteins, TandAb, Ig DART, and further complex biologics like bi- or multispecific mAbs
Microbial Technologies
Clinical and commercial supply
Refolding, large-scale HPLC and chemical
modifications to prolong molecule half-lifeSeveral plasmid-based gene expression
systems for E. coli, yeast and PseudomonasGenetic engineering
Cell line and strain development
Fast and tailored project transfers
Process and analytical development
Upstream and downstream processing
Large-scale GMP facilities licensed by EMA, FDA & MHLW
GMP batch release testing
Manufacturing of Fab fragment, peptide
hormones, plasmid DNA, scaffolds,
recombinant proteins, enzymes and
recombinant vaccines
Aseptic Filling
Clinical and commercial capacities and
technology for vialsFormulations for liquids and lyophilizates vials
Flexible filling volumes for clinical and
commercial supplyManual and automated visual inspections
Globally licensed (e.g. FDA, EMA, PMDA,
ANVISA) multi product facilities